Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atazanavir/ritonavir with optimized NRTI background therapy in pediatric HIV
2011-003300-21Phase 4
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of atazanavir and ritonavir in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Primary endpoint: Safety and tolerability.
02
Drugs
atazanavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2011-003300-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003300-21.